Phase I Clinical Trial of Suberoylanilide Hydroxamic Acid (SAHA) in Combination With Pemetrexed and Cisplatin in Patients With Advanced Cancer.
Phase of Trial: Phase I
Latest Information Update: 12 May 2009
At a glance
- Drugs Cisplatin; Pemetrexed; Vorinostat
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Merck & Co
- 30 Jul 2008 Status changed from in progress to completed, as reported on clinicaltrials.gov
- 08 Feb 2008 Status change from recruiting to in progress.
- 14 Nov 2007 Trial centre added.